Literature DB >> 21323904

Activation of vascular KCNQ (Kv7) potassium channels reverses spasmogen-induced constrictor responses in rat basilar artery.

Bharath K Mani1, Lioubov I Brueggemann, Leanne L Cribbs, Kenneth L Byron.   

Abstract

BACKGROUND AND
PURPOSE: Cerebral vasospasm is the persistent constriction of large conduit arteries in the base of the brain. This pathologically sustained contraction of the arterial myocytes has been attributed to locally elevated concentrations of vasoconstrictor agonists (spasmogens). We assessed the presence and function of KCNQ (K(v) 7) potassium channels in rat basilar artery myocytes, and determined the efficacy of K(v) 7 channel activators in relieving spasmogen-induced basilar artery constriction. EXPERIMENTAL APPROACH: Expression and function of K(v) 7 channels in freshly isolated basilar artery myocytes were evaluated by reverse transcriptase polymerase chain reaction and whole-cell electrophysiological techniques. Functional responses to K(v) 7 channel modulators were studied in intact artery segments using pressure myography. KEY
RESULTS: All five mammalian KCNQ subtypes (KCNQ1-5) were detected in the myocytes. K(v) currents were attributed to K(v) 7 channel activity based on their voltage dependence of activation (V(0.5) ∼-34 mV), lack of inactivation, enhancement by flupirtine (a selective K(v) 7 channel activator) and inhibition by 10,10-bis(pyridin-4-ylmethyl)anthracen-9-one (XE991; a selective K(v) 7 channel blocker). XE991 depolarized the myocytes and constricted intact basilar arteries. Celecoxib, a clinically used anti-inflammatory drug, not only enhanced K(v) 7 currents but also inhibited voltage-sensitive Ca(2+) currents. In arteries pre-constricted with spasmogens, both celecoxib and flupirtine were more effective in dilating artery segments than was nimodipine, a selective L-type Ca(2+) channel blocker. CONCLUSIONS AND IMPLICATIONS: K(v) 7 channels are important determinants of basilar artery contractile status. Targeting the K(v) 7 channels using flupirtine or celecoxib could provide a novel strategy to relieve basilar artery constriction in patients with cerebral vasospasm. LINKED ARTICLES: To view two letters to the Editor regarding this article visit http://dx.doi.org/10.1111/j.1476-5381.2011.01454.x and http://dx.doi.org/10.1111/j.1476-5381.2011.01457.x.
© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21323904      PMCID: PMC3174403          DOI: 10.1111/j.1476-5381.2011.01273.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  42 in total

1.  Vasopressin-induced vasoconstriction: two concentration-dependent signaling pathways.

Authors:  Kyle K Henderson; Kenneth L Byron
Journal:  J Appl Physiol (1985)       Date:  2007-01-04

Review 2.  Kv7 (KCNQ) channel modulators and neuropathic pain.

Authors:  Gordon Munro; William Dalby-Brown
Journal:  J Med Chem       Date:  2007-05-10       Impact factor: 7.446

3.  Non-L-type voltage-dependent calcium channels control vascular tone of the rat basilar artery.

Authors:  Manuel F Navarro-Gonzalez; T Hilton Grayson; Kate R Meaney; Leanne L Cribbs; Caryl E Hill
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-08-26       Impact factor: 2.557

4.  Vasopressin stimulates action potential firing by protein kinase C-dependent inhibition of KCNQ5 in A7r5 rat aortic smooth muscle cells.

Authors:  Lioubov I Brueggemann; Christopher J Moran; John A Barakat; Jay Z Yeh; Leanne L Cribbs; Kenneth L Byron
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-10-27       Impact factor: 4.733

5.  Voltage-gated K+ channel dysfunction in myocytes from a dog model of subarachnoid hemorrhage.

Authors:  Babak S Jahromi; Yasuo Aihara; Jinglu Ai; Zhen-Du Zhang; Elena Nikitina; Robert Loch Macdonald
Journal:  J Cereb Blood Flow Metab       Date:  2007-11-07       Impact factor: 6.200

6.  Vascular KCNQ potassium channels as novel targets for the control of mesenteric artery constriction by vasopressin, based on studies in single cells, pressurized arteries, and in vivo measurements of mesenteric vascular resistance.

Authors:  Alexander R Mackie; Lioubov I Brueggemann; Kyle K Henderson; Aaron J Shiels; Leanne L Cribbs; Karie E Scrogin; Kenneth L Byron
Journal:  J Pharmacol Exp Ther       Date:  2008-02-13       Impact factor: 4.030

Review 7.  Molecular pharmacology and therapeutic potential of neuronal Kv7-modulating drugs.

Authors:  Francesco Miceli; Maria Virginia Soldovieri; Maria Martire; Maurizio Taglialatela
Journal:  Curr Opin Pharmacol       Date:  2007-12-03       Impact factor: 5.547

8.  Preserved BK channel function in vasospastic myocytes from a dog model of subarachnoid hemorrhage.

Authors:  Babak S Jahromi; Yasuo Aihara; Jinglu Ai; Zhen-Du Zhang; George Weyer; Elena Nikitina; Reza Yassari; Khaled M Houamed; R Loch Macdonald
Journal:  J Vasc Res       Date:  2008-04-10       Impact factor: 1.934

9.  Molecular expression and pharmacological identification of a role for K(v)7 channels in murine vascular reactivity.

Authors:  S Y M Yeung; V Pucovský; J D Moffatt; L Saldanha; M Schwake; S Ohya; I A Greenwood
Journal:  Br J Pharmacol       Date:  2007-05-21       Impact factor: 8.739

10.  Opposite regulation of KCNQ5 and TRPC6 channels contributes to vasopressin-stimulated calcium spiking responses in A7r5 vascular smooth muscle cells.

Authors:  Bharath K Mani; Lioubov I Brueggemann; Leanne L Cribbs; Kenneth L Byron
Journal:  Cell Calcium       Date:  2009-02-25       Impact factor: 6.817

View more
  22 in total

1.  Kv7 potassium channels in airway smooth muscle cells: signal transduction intermediates and pharmacological targets for bronchodilator therapy.

Authors:  Lioubov I Brueggemann; Priyanka P Kakad; Robert B Love; Julian Solway; Maria L Dowell; Leanne L Cribbs; Kenneth L Byron
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-09-30       Impact factor: 5.464

2.  KV7 Channel Pharmacological Activation by the Novel Activator ML213: Role for Heteromeric KV7.4/KV7.5 Channels in Guinea Pig Detrusor Smooth Muscle Function.

Authors:  Aaron Provence; Damiano Angoli; Georgi V Petkov
Journal:  J Pharmacol Exp Ther       Date:  2017-10-30       Impact factor: 4.030

3.  Vasorelaxant effects of novel Kv 7.4 channel enhancers ML213 and NS15370.

Authors:  T A Jepps; B H Bentzen; J B Stott; O V Povstyan; K Sivaloganathan; W Dalby-Brown; I A Greenwood
Journal:  Br J Pharmacol       Date:  2014-08-14       Impact factor: 8.739

Review 4.  Non-steroidal anti-inflammatory drugs in the pathophysiology of vasospasms and delayed cerebral ischemia following subarachnoid hemorrhage: a critical review.

Authors:  Peter Solar; Zdenek Mackerle; Marek Joukal; Radim Jancalek
Journal:  Neurosurg Rev       Date:  2020-03-02       Impact factor: 3.042

Review 5.  Flupirtine, a re-discovered drug, revisited.

Authors:  Istvan Szelenyi
Journal:  Inflamm Res       Date:  2013-01-16       Impact factor: 4.575

Review 6.  One man's side effect is another man's therapeutic opportunity: targeting Kv7 channels in smooth muscle disorders.

Authors:  T A Jepps; S P Olesen; I A Greenwood
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

Review 7.  Ion channel remodeling in vascular smooth muscle during hypertension: Implications for novel therapeutic approaches.

Authors:  Biny K Joseph; Keshari M Thakali; Christopher L Moore; Sung W Rhee
Journal:  Pharmacol Res       Date:  2013-01-31       Impact factor: 7.658

8.  Chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3 regulate vascular α₁-adrenergic receptor function.

Authors:  Harold H Bach; Yee M Wong; Abhishek Tripathi; Amanda M Nevins; Richard L Gamelli; Brian F Volkman; Kenneth L Byron; Matthias Majetschak
Journal:  Mol Med       Date:  2014-10-13       Impact factor: 6.354

9.  Vascular KCNQ (Kv7) potassium channels as common signaling intermediates and therapeutic targets in cerebral vasospasm.

Authors:  Bharath K Mani; James O'Dowd; Lalit Kumar; Lioubov I Brueggemann; Masey Ross; Kenneth L Byron
Journal:  J Cardiovasc Pharmacol       Date:  2013-01       Impact factor: 3.105

10.  Kv7.5 Potassium Channel Subunits Are the Primary Targets for PKA-Dependent Enhancement of Vascular Smooth Muscle Kv7 Currents.

Authors:  Bharath K Mani; Christina Robakowski; Lyubov I Brueggemann; Leanne L Cribbs; Abhishek Tripathi; Matthias Majetschak; Kenneth L Byron
Journal:  Mol Pharmacol       Date:  2015-12-23       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.